The exclusion of pathological involvement of mediastinal lymph nodes in patients affected by NSCLC plays a central role in assessing their prognosis and operability. Ceron et al. developed a software - called M.E.S.S.i.a (Mediastinal Evaluation with Statistical Support; instant approach) - that allows the calculation of the residual probability of lymph node involvement after a certain number of tests has been done, by integrating every test result with the pre-test prevalence. M.E.S.S.i.a. bridges a gap of current American College of Chest Physicians (ACCP) guidelines, providing probability values of mediastinal metastasis for a correct clinical decision. We conducted a preliminary retrospective study in a series of 108 patients affected by non small cell lung cancer (NSCLC). Pathological staging was compared to the probability of nodal involvement calculated by M.E.S.S.i.a. software. Forty-two out of 108 subjects (39%) had a calculated post-test probability <8%; none of these had proven N2/N3 metastasis at surgical staging (negative predictive value, NPV: 100%). In 12/41 cases M.E.S.S.i.a. was able to avoid invasive procedures. The remaining 66 (61%) patients did not reach the surgical threshold; among these, 11 displayed N2 positivity at pathological staging. Receiving operator curve (ROC) analysis produced an area under curve (AUC) value of 0.773 (p<0.001). These preliminary data show high accuracy of M.E.S.S.i.a. software in excluding N2/N3 lymph node involvement in NSCLC. We have therefore promoted a prospective multicenter study in order to to get a validation of the calculator at different levels of probability of lymph node involvement. The recruitable subjects are potentially operable NSCLC patients; the gold standard for detection of mediastinal disease is the surgical lymph node dissection.
Background: Iatrogenic tracheal injuries are uncommon yet potentially life-threatening complications of airway management and thoracic interventions. Although awareness of post-intubation tracheal lacerations (PiTLs) has increased over recent decades, their management remains largely constructed on institutional experience, and standardized evidence-based recommendations are lacking. The Italian Society of Thoracic Endoscopy (SIET) therefore developed this position paper to provide practical guidance for the di-agnosis, classification, and management of PiTLs. Methods: A structured narrative review and expert consensus process were conducted to evaluate key diagnostic and therapeutic aspects of PiTL. PubMed/MEDLINE and Scopus were searched from January 2000 through June 2026. Preliminary statements were de-veloped, reviewed, and refined through structured discussion by an 20-member panel of experts in thoracic surgery, interventional pulmonology, and anesthesiology. The re-sulting statements reflect the collective judgment of the expert panel and are intended as consensus-based recommendations within a position paper. Results: Flexible bronchoscopy remains the diagnostic gold standard to assess the precise location, length, depth, and circumferential involvement of the lesion. Management strategies are highly driven by physiological stability, ventilatory status, and morpho-logical characteristics, primarily using the Cardillo classification system. Conservative treatment is indicated for stable, spontaneously breathing patients (Cardillo Level I–II and selected IIIA), while early surgical intervention (within 24 hours) is recommended for severe cases with ventilatory instability or major complications (Cardillo Level IIIB–IV). Conclusions: PiTLs require early, comprehensive, and structured diagnostic evaluation, followed by individualized management. Adherence to the 17 SIET position statements provides a standardized framework for clinical decision-making and may help reduce variability in care.